STERIS Announces Expansion of Chonburi, Thailand Facility to Include Gamma Processing

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the addition of radiation processing services in Thailand.   The addition of gamma sterilization services in Thailand furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and…

Details

Luer Testing Services at the STERIS Galway, Ireland Facility

The STERIS Galway, Ireland facility provides tailored service packages to assist Customers with regulatory submissions to support designers through the luer compliance process. These services range from early-stage CAD reviews and test protocol generation to complete test execution and reporting. The team at the Galway facility has extensive technical training and can offer ISO 17025-accredited tests…

Details

Laboratory Expansion at STERIS Tullamore, Ireland Facility  

Mark Botting, Director, Global Laboratories.  Earlier this year, we celebrated the official opening of the expanded laboratory at the STERIS Tullamore, Ireland facility. The laboratory expansion complements the existing electron beam and ethylene oxide sterilization services offered at the Tullamore facility. The occasion was marked by the attendance of a large number of Irish medical…

Details

STERIS ADDS VHP TO ITS PORTFOLIO OF TECHNOLOGY-NEUTRAL STERILIZATION OPTIONS

STERIS Applied Sterilization Technologies (AST) is pleased to announce that vaporized hydrogen peroxide (VHP) sterilization services are now available as part of our global contract sterilization offering.   VHP is a deep vacuum, low-temperature process compatible with a wide range of polymeric materials, making it an effective sterilization method for a variety of healthcare products,…

Details

STERIS SUBMISSIONS SELECTED AS PART OF FDA INNOVATION CHALLENGE

In July 2019, the U.S. Food and Drug Administration (FDA) announced two innovation challenges to encourage the development of new approaches to contract sterilization of single-use medical devices. On November 25, 2019, the Agency announced that 46 applications were received as part of the challenge and 13 were selected.   STERIS is excited to announce…

Details

STERIS AST Testing and Validation Services Annual Review

Mark Botting, Director of Global Laboratories As part of our long-term commitment to supporting global medical device manufacturing, STERIS’s network of microbiological testing laboratories has continued to grow over the past year. New and expanded laboratories in the United States, Italy, and Germany broaden our capacity to deliver a range of testing services that support…

Details